What is the current Ibuprofen for External Use market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Ibuprofen for External Use market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Ibuprofen for External Use market?

Increasing demand for topical pain relief and rising awareness of ibuprofen's benefits drive the market.

What are the major challenges facing the Ibuprofen for External Use market?

Stringent regulatory requirements and competition from alternative pain relief products are key challenges.

Which regions are the leaders in the Ibuprofen for External Use market?

North America and Europe are the leading regions due to high demand and established healthcare infrastructure.

Who are the top companies in the Ibuprofen for External Use market?

Leading companies include Johnson & Johnson, Pfizer, and GlaxoSmithKline, which offer a range of topical ibuprofen products.

What future opportunities exist in the Ibuprofen for External Use market?

Emerging markets and increasing demand for over-the-counter pain relief products present growth opportunities.

How does technology impact the Ibuprofen for External Use market?

Advances in formulation technology and digital marketing strategies enhance product development and customer engagement.

What is the current regulatory landscape for the Ibuprofen for External Use market?

Regulatory bodies such as the FDA and EMA oversee the market, ensuring compliance with safety and efficacy standards.

What is the future outlook for the Ibuprofen for External Use market?

The market is expected to experience steady growth, driven by increasing demand for effective topical pain relief solutions.

Ibuprofen for External Use Growth Opportunities & Strategic Forecast 2033

Ibuprofen for External Use by Application (Online Sales, Offline Sales), by Types (Cream, Gel, Spray), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Ibuprofen for External Use Market Size | CAGR 5.2 Forecast 2033

Ibuprofen for External Use Growth Opportunities & Strategic Forecast 2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Ibuprofen for External Use Market Overview

The Ibuprofen for External Use market refers to the industry segment focused on the development, production, and distribution of ibuprofen-based products for external application, such as creams, gels, and sprays. As the global population ages and the prevalence of musculoskeletal disorders increases, the Ibuprofen for External Use market size is expected to experience significant growth, driven by its growth outlook and market forecast. The industry expansion is anticipated to be substantial, with the global Ibuprofen for External Use market size valued at approximately $1.3 billion in 2025. The market forecast suggests a compound annual growth rate (CAGR) of around 5.5% during the forecast period from 2026 to 2033, driven by macro drivers such as increasing demand for topical pain relief products and rising awareness about the benefits of ibuprofen-based treatments.

Loading chart…

The Ibuprofen for External Use market is shaped by several key forces, including technology shifts towards more effective and targeted delivery systems, regulations governing the approval and marketing of topical pain relief products, and consumer behavior driven by increasing demand for convenient and non-invasive treatments. The largest region for the Ibuprofen for External Use market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rising healthcare expenditure and growing awareness about the benefits of ibuprofen-based treatments. As the industry continues to evolve, competitive intensity and supply-chain dynamics are likely to play a crucial role in shaping the market landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	19.20 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medico Remedies Ltd.; Dermal; Eipico; Mentholatum SA; Nurofen; GSK; Kangzheng Pharmaceutical Co.,Ltd.; Youcare; HAPHARM GROUP CO.,LTD.; Zhuhai Aofute Medtech Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Ibuprofen for External Use market is poised for significant growth, driven by increasing demand for topical pain relief solutions. As the market continues to evolve, understanding the underlying dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Rising prevalence of musculoskeletal disorders and associated pain management needs are expected to fuel the Ibuprofen for External Use market size, with a substantial growth forecast anticipated over the next five years.

Advancements in formulation technologies, such as nano-emulsions and micro-emulsions, are enhancing the efficacy and stability of ibuprofen-based topical products, further driving market expansion.

Restraints2 items

Stringent regulatory requirements and varying approval processes across different regions may hinder the launch of new Ibuprofen for External Use products, potentially impacting market growth.

Increasing competition from alternative topical pain relief therapies, including CBD-based products and physical therapy modalities, may constrain the market's growth prospects.

Opportunities2 items

The growing demand for over-the-counter (OTC) pain relief solutions presents a significant opportunity for manufacturers to develop and market Ibuprofen for External Use products, particularly in regions with limited access to prescription-based therapies.

Strategic partnerships and collaborations between pharmaceutical companies and specialty pharmacies can facilitate the development and commercialization of innovative ibuprofen-based topical products, addressing unmet needs in the market.

Challenges2 items

Ensuring the Ibuprofen for External Use market remains competitive amidst intense pricing pressures and fluctuating raw material costs poses a significant challenge for manufacturers, requiring strategic pricing and supply chain management.

Maintaining product quality and safety while adhering to evolving regulatory standards and addressing concerns related to skin irritation and allergic reactions is essential for manufacturers to mitigate potential risks and reputational damage.

Market Segmentation

Loading chart…

The Ibuprofen for External Use segmentation by Application refers to the various uses of ibuprofen in treating external conditions. This segment contributes significantly to the overall market size, as ibuprofen is widely used to relieve pain and reduce inflammation in conditions such as sprains, strains, and muscle aches. The application segment can be further divided into subtypes, including sports medicine, physical therapy, and first aid treatments.

The Types segment of the Ibuprofen for External Use market refers to the different forms in which ibuprofen is available for external use, such as creams, gels, and sprays. This segment is crucial in determining the overall market size, as different types of ibuprofen products cater to various consumer preferences and needs. The types segment can be further divided into subtypes, including topical creams and transdermal patches, each with its own set of characteristics and benefits. Understanding the market taxonomy of ibuprofen types is essential for businesses to develop effective strategies and products that meet consumer demands.

Ibuprofen for External Use Segmentation Breakdown7 items

Application

Online Sales

Offline Sales

Types

Cream

Gel

Spray

Regional Insights

Loading chart…

The Ibuprofen for External Use market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Latin America, driven by increasing adoption of ibuprofen-based topical products, favorable policies, and rising investments in the healthcare sector.

In North America, key drivers include a mature ecosystem, high demographics awareness, and established infrastructure. Europe is driven by a strong regulatory framework, growing demand for topical pain relief products, and a high level of ecosystem maturity. Asia Pacific's growth is fueled by a large patient population, increasing healthcare expenditure, and a rising middle-class population. Latin America's growth is driven by expanding distribution channels, growing awareness of ibuprofen-based products, and improving economic conditions. The Middle East & Africa region is expected to witness moderate growth, driven by increasing healthcare spending, rising demand for pain management products, and a growing pharmaceutical market.

The regional forecast indicates that the Ibuprofen for External Use market will experience significant growth in the coming years, driven by increasing adoption of topical pain relief products, favorable policies, and rising investments in the healthcare sector. As the market continues to evolve, it is essential to monitor regional trends and market dynamics to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The Ibuprofen for External Use market is moderately consolidated, with a mix of global players and local/regional companies. The Ibuprofen for External Use competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and regulatory approvals to maintain their market position, while local companies are relying on pricing and distribution strategies to compete.

Companies are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies are focusing on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies are implementing these strategies:

Medico Remedies Ltd. regional expansion

Dermal premium pricing

Eipico innovation pipeline

Mentholatum SA local manufacturing

Nurofen OEM tie-ups

GSK vertical integration

Key Ibuprofen for External Use Companies10 items

Medico Remedies Ltd.

Dermal

Eipico

Mentholatum SA

Nurofen

GSK

Kangzheng Pharmaceutical Co.,Ltd.

Youcare

HAPHARM GROUP CO.,LTD.

Zhuhai Aofute Medtech Co.,Ltd.

Market Ecosystem

The Ibuprofen for External Use ecosystem encompasses a complex network of stakeholders, spanning upstream suppliers of raw materials to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where technology providers and raw material suppliers create value through innovation and sourcing; midstream, where integrators and manufacturers convert these inputs into finished products; and downstream, where channels and end users ultimately capture value through product sales and consumption.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce finished ibuprofen products

Technology providers — develop formulation and production technologies

System integrators / EPCs — integrate ibuprofen into final products

Distributors / channel partners — facilitate product distribution

Regulators/standards bodies — oversee safety and efficacy standards

End users / buyers — consume ibuprofen products for external use

Within the Ibuprofen for External Use ecosystem, value flows through the creation and capture of innovative products, manufacturing efficiencies, and regulatory compliance. Control points, such as regulatory approvals and supply chain dependencies, can significantly influence adoption rates and product availability. Furthermore, the ecosystem's dependency on input supplies, standards, and approvals introduces risks, including potential bottlenecks and switching costs. As a result, understanding the intricacies of this ecosystem through a thorough value chain analysis is crucial for navigating the complex interactions and relationships that govern the Ibuprofen for External Use market.

Recent Industry Insights

The Ibuprofen for External Use industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product formulations and expanding distribution networks. Notable mergers and acquisitions have also led to increased market consolidation, driving growth and innovation in the industry. Furthermore, several companies have launched new products and technologies, including topical creams and gels, to cater to the rising demand for effective and convenient pain relief solutions.

Regulatory changes have also played a crucial role in shaping the industry, with authorities implementing stricter guidelines for product safety and efficacy. Additionally, there has been a shift in consumer trends, with a growing preference for non-invasive and non-pharmacological treatments, driving the demand for ibuprofen-based topical products. Funding rounds and expansions have also been observed, enabling companies to invest in research and development, and scale up their operations to meet the increasing demand for ibuprofen-based products.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Ibuprofen for External Use market. The market attractiveness is moderate, driven by increasing demand for topical pain relief solutions. The competitive intensity is high, with several established players competing for market share. Looking at the long-term Ibuprofen for External Use market outlook, I anticipate steady growth, driven by innovation in formulation and delivery systems.

The innovation landscape is evolving, with a focus on sustained release formulations and nanotechnology to enhance efficacy and patient compliance. However, the demand–supply balance may be affected by regulatory changes and raw material shortages. Key risk factors include intense competition, pricing pressure, and evolving regulatory requirements, which may impact market growth and profitability.

11 items

1. Executive Summary

2. Ibuprofen for External Use Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Ibuprofen for External Use Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Ibuprofen for External Use Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Online Sales

6.1.2. Offline Sales

6.2. Global Ibuprofen for External Use Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Cream

6.2.2. Gel

6.2.3. Spray

6.3. Global Ibuprofen for External Use Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Ibuprofen for External Use Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Ibuprofen for External Use Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Ibuprofen for External Use Market Competition by Key Manufacturers

8.1. Global Ibuprofen for External Use Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Ibuprofen for External Use: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medico Remedies Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Dermal

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Eipico

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Mentholatum SA

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Nurofen

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. GSK

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Kangzheng Pharmaceutical Co.,Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Youcare

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. HAPHARM GROUP CO.,LTD.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Zhuhai Aofute Medtech Co.,Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Ibuprofen for External Use Market

Figure 4: Global Ibuprofen for External Use Market: Drivers

Figure 5: Global Ibuprofen for External Use Market: Challenges

Figure 6: Global Ibuprofen for External Use Market: Trends

Figure 7: Global Ibuprofen for External Use Market: Opportunity

Figure 8: Global Ibuprofen for External Use Market: Restraint

Figure 9: Global Ibuprofen for External Use Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Ibuprofen for External Use Market Value (USD Million) By Region

Figure 15: Global Ibuprofen for External Use Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Ibuprofen for External Use Market Value (USD Million) By Region

Figure 23: Global Ibuprofen for External Use Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Ibuprofen for External Use Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Ibuprofen for External Use Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Ibuprofen for External Use Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Ibuprofen for External Use Market Value (USD Million) By Region

Table 10: Global Ibuprofen for External Use Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Ibuprofen for External Use Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Ibuprofen for External Use Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Ibuprofen for External Use Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medico Remedies Ltd. Basic Information And Sales Area

Table 31: Medico Remedies Ltd.. Products Portfolio

Table 32: Dermal Basic Information And Sales Area

Table 33: Dermal. Products Portfolio

Table 34: Eipico Basic Information And Sales Area

Table 35: Eipico. Products Portfolio

Table 36: Mentholatum SA Basic Information And Sales Area

Table 37: Mentholatum SA. Products Portfolio

Table 38: Nurofen Basic Information And Sales Area

Table 39: Nurofen. Products Portfolio

Table 40: GSK Basic Information And Sales Area

Table 41: GSK. Products Portfolio

Table 42: Kangzheng Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 43: Kangzheng Pharmaceutical Co.,Ltd.. Products Portfolio

Table 44: Youcare Basic Information And Sales Area

Table 45: Youcare. Products Portfolio

Table 46: HAPHARM GROUP CO.,LTD. Basic Information And Sales Area

Table 47: HAPHARM GROUP CO.,LTD.. Products Portfolio

Table 48: Zhuhai Aofute Medtech Co.,Ltd. Basic Information And Sales Area

Table 49: Zhuhai Aofute Medtech Co.,Ltd.. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Ibuprofen for External Use Market Value (USD Million) By Region

Table 55: Global Ibuprofen for External Use Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Ibuprofen for External Use Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	19.20 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medico Remedies Ltd.; Dermal; Eipico; Mentholatum SA; Nurofen; GSK; Kangzheng Pharmaceutical Co.,Ltd.; Youcare; HAPHARM GROUP CO.,LTD.; Zhuhai Aofute Medtech Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options